| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5e7a9f9b6aa26ac3a15dfb7b4c82bc2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 |
| filingDate |
2013-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4897861704d2c5eb75a501a2d9df9b09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f29959efb60c3211ea6cb02e9d8597e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_885609f4acb24a39a608db55c869bd18 |
| publicationDate |
2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150027800-A |
| titleOfInvention |
Prophylactic and/or therapeutic agent for mild cognitive impairment |
| abstract |
The present invention provides a preventive and / or therapeutic agent for mild to moderate disturbance by cleansing harmful proteins accumulating in the brain by improving interstitial flow of cerebral blood vessels and the like. The prophylactic and / or therapeutic agent may be selected from the group consisting of 6- [4- (1-cyclohexyl) -1H-tetrazole-5-yl (yl)) butoxy] Dihydrocarbostyril or salts thereof as an active ingredient. As a result, the flow of the discharge route of the perivascular interstitial fluid is improved, and harmful proteins are released. The preventive and / or therapeutic agent for the hardness-related disorder of the present invention can be formulated as an oral preparation, an oral liquid preparation, or an injection. The preventive and / or therapeutic agent for the hardness-related disorder of the present invention can be used for the prevention and / or treatment of cerebral amyloid angiopathy, and is also used for the improvement of Louis soche disease, Down syndrome or macular degeneration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190004336-A |
| priorityDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |